The Feasibility of Integrating the Noble Scallop Mimachlamys nobilis with Existing Fish Monoculture Farms in the South China Sea: A Bioeconomic Assessment from Hong Kong

The environmental implications of integrated multitrophic aquaculture have been well studied in China, but few investigations have empirically explored potential economic benefits. This study investigated the technical and economic feasibility of physically integrating the noble scallop Mimachlamys nobilis (Reeve, 1852) with existing fish monoculture farms in Hong Kong. Scallops were grown for 201 days from June to December in lantern nets hung directly from fish farm platforms at treatment depths of 1, 3.5, and 6 m. Only the 1-m treatment attained the target mean height-at-harvest of 80 mm. Fitted von Bertalanffy growth functions showed significant differences in growth performance between depths. The von Bertalanffy growth function projected that the 3.5- and 6-m treatments would require an additional 26 and 59 days of culture to reach 80 mm. Mortality was significantly lower at 1 m (53% ± 12.5%) compared with those at 3.5 m (70% ± 9.0%) and 6 m (83% ± 4.5%). The slower growth and higher mortality at 3.5 and 6mwere probably due to periodically low oxygen which dropped to 4.96, 3.08, and 1.73 mg L-1 at 1, 3.5, and 6 m, respectively, in midsummer. A bioeconomic assessments of two typical farm sizes was conducted; small (45 m2) and large (315 m2). The initial investment, discounted payback time, and 10-y net present value of the projects was US$5,485.51, 3 y, and US$20,211.33, respectively, for the small farm and US$27,659.03, 2 y, and US$227,406.49, respectively, for the large farm. Sensitivity analysis revealed that the profitability of operations was sensitive to changes in mortality and sales price. This study has confirmed that physically integrating M. nobilis at existing fish farms is technically and economically feasible

Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway

Pancreatic ductal adenocarcinoma (PDAC) has one of the highest mortality rates and requires the development of highly efficacious medications that can improve the efficiency of existing treatment methods. In particular, in PDAC, resistance to conventional chemotherapy reduces the effectiveness of anticancer drugs, decreasing the therapeutic efficiency. Sphingosine 1-phosphate (S1P), produced by sphingosine kinase (SK), plays a vital role in cancer growth, metastasis, chemotherapy, and drug resistance. Focusing on the structural characteristics of mebendazole (MBZ), we studied whether MBZ would affect metastasis, invasion, and drug resistance in cancer by lowering S1P production through inhibition of SK activity. MBZ selectively inhibited SK1 more than SK2 and regulated the levels of sphingolipids. MBZ inhibited the proliferation and migration of cancer cells in other PDAC cell lines. To determine whether the effect of MBZ on cancer cell growth and migration is S1P-mediated, S1P was treated, and the growth and migration of cancer cells were observed. It was found that MBZ inhibited S1P-induced cancer cell growth, and MBZ showed a growth inhibitory effect by regulating the JAK2/STAT3/Bcl-2 pathway. The phosphorylation of focal adhesion kinase (FAK), a transcription factor that regulates migration, was inhibited by MBZ, so it was found that the effect of MBZ regulates the migration of cancer cells through the S1P/FAK/vimentin pathway. In conclusion, our study suggests that the anthelmintic MBZ can be used as a potential therapeutic agent for treating PDAC and for structural synthesis studies of its analogs